The authors recommend tweaking pelvic ultrasound with new maneuvers that produce clearer images.

The new platform is the first redesign from Siemens Healthineers in over a decade.

The two companies have partnered on a new FDA-cleared CT injection system for the early detection of breast cancer.

The Embolize Trial will test multiple procedures and assess any reduction in pain scores and medication usage.

In a study presented at the Society of Interventional Radiology Annual Scientific Meeting, the procedure reduced hysterectomies by 94%.

The study, presented at the Society of Interventional Radiology Annual Scientific Meeting, marks one of the first to use freezing on large tumors in the breast.